It is tempting to speculate that this apparent loss of benefit in patients with more advanced HF may be the result of increases in HR caused by activation of sinoatrial node (SAN) GLP-1Rs (64, 65), which could be mitigated with an agent such as GLP-1(2836) that retains cardiac and vascular protection of GLP-1, without activating the GLP-1R
Neves JS, Vasques-Novoa F, Borges-Canha M, Leite AR, Sharma A, Carvalho D, Packer M, Zannad F, Leite-Moreira A, Ferreira JP
Limitations of L-Carnitine Varied Results Some studies have investigated L-carnitine weight loss results and discovered mixed findings
Pyridoxine dependency: an update
The peptides and small molecules under development elicit weight loss by mimicking amylin, a naturally occurring hormone that plays a role in glucose regulation
Weeks 5 through 12: the new normal The novelty of reduced food noise fades, and a new baseline emerges